Faeth Therapeutics Inc. – Filings and Transcripts

NASDAQ: FTH
Share price (8/14/26): $32.34
Market cap (8/14/26): $836 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 12/31/25 FY 2025 – amended

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Automatic shelf registration

Shelf registration – amended

Shelf registration – amended

Registration of securities for employees

Shelf registration

Ownership Filter

Caligan Partners LP

Trails Edge Capital Partners, LP

Khosla Ventures VI, L.P.

Stempoint Capital LP

Cambrian BioPharma Inc

News Filter

Reports Second Quarter 2026 Financial Results and Operational Updates

Change in Directors, Officers or Compensation

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission